GRCEHIGH SIGNALREGULATORY10-K

GRCE completed a major corporate restructuring, reincorporating from Quebec, Canada to Delaware while substantially reducing total liabilities and changing its share structure.

The reincorporation from Canada to Delaware represents a fundamental corporate transformation that typically signals a company's intention to align more closely with U.S. capital markets and governance standards. The concurrent 47% increase in outstanding shares (from 9.4M to 13.8M) and change from no-par to $0.0001 par value shares suggests significant equity restructuring or potential financing activity that investors should investigate further.

Comparing 2025-06-23 vs 2024-06-21View on EDGAR →
FINANCIAL ANALYSIS

The company's financial position shows mixed signals with total liabilities declining meaningfully by 53% to $5.4M, indicating debt reduction or restructuring benefits. However, operating performance deteriorated with operating losses expanding and operating cash flow declining by approximately 21%. While net losses narrowed modestly, the overall picture reflects a company undergoing significant structural changes while still burning cash and struggling with operational profitability.

FINANCIAL STATEMENT CHANGES
Total Liabilities
Balance Sheet
-53.4%
$11.6M→$5.4M

Liabilities reduced 53.4% — deleveraging improves balance sheet strength and financial flexibility.

Operating Income
P&L
-29.8%
-$12.9M→-$16.7M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Net Income
P&L
+25.6%
-$12.9M→-$9.6M

Net income grew 25.6% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
-20.8%
-$12.3M→-$14.9M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Current Liabilities
Balance Sheet
+14.6%
$1.7M→$1.9M

Current liabilities rose 14.6% — increased short-term obligations, watch current ratio.

LANGUAGE CHANGES
NEW — 2025-06-23
PRIOR — 2024-06-21
ADDED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.
(Exact name of registrant as specified in its charter) State of Delaware 98-1359336 (State or other jurisdiction of incorporation or organization) (I.R.S.
The number of outstanding shares of common stock of the registrant, par value $0.0001 per share, as of June 19, 2025, was 13,828,562 .
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 54 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operation 55 Item 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 63 Item 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 64 Item 13.
federal securities laws and forward-looking information within the meaning of Canadian securities laws, both of which we refer to in this Annual Report on Form 10-K as forward-looking statements.
Forward-looking statements can be identified by the use of terms such as may, will, should, expect, plan, anticipate, believe, intend, estimate, predict, potential, continue, or other similar expressions concerning matters that are not statements about the present or historical facts.
Approval of our drug candidates could be delayed, limited, or denied if the FDA does not approve and maintain the approval of our contract manufacturers processes or facilities; the design, development, manufacture, supply, and distribution of our drug candidates are highly regulated and technically complex; and the other risks and uncertainties identified in Item 1A.
REMOVED
(Exact name of registrant as specified in its charter) Qu bec, Canada 98-1359336 (State or other jurisdiction of incorporation or organization) (I.R.S.
The number of outstanding common shares of the registrant, no par value per share, as of June 21, 2024 , was 9,399,404 .
Auditor Firm Id: 185 Auditor Name: KPMG LLP Auditor Location: Philadelphia, Pennsylvania, United States Former Auditor Firm Id: 1263 Auditor Name: Ernst Young LLP Auditor Location: Montr al, QC, Canada ACASTI PHARMA INC.
Market for Registrant s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities 48 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operation 54 Item 7A .
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 63 Item 9A .
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters 77 Item 13.
federal securities laws, both of which we refer to in this Annual Report on Form 10-K as forward-looking information.
Forward-looking information can be identified by the use of terms such as may , will , should , expect , plan , anticipate , believe , intend , estimate , predict , potential , continue or other similar expressions concerning matters that are not statements about the present or historical facts.
Except as otherwise indicated, references in this Annual Report on Form 10-K to Acasti, the Company, we, us and our refer to Acasti Pharma Inc.
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →